Skip to main content
Log in

Acitretin/cemiplimab/fluorouracil

Various toxicities and lack of efficacy: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Akhtar K, et al. Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios. Journal of Investigative Medicine High Impact Case Reports 10: Jan-Dec 2022. Available from: URL: http://doi.org/10.1177/23247096221121408

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acitretin/cemiplimab/fluorouracil. Reactions Weekly 1932, 19 (2022). https://doi.org/10.1007/s40278-022-27384-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-27384-0

Navigation